Items of recent pandemic news: A resource for finding authorized therapeutics in the US; how long booster shots protect; an early study isolating ultrapotent antibodies from elite neutralizers; and a new variant on the Omicron variant. Plus a frippery. Quotes … Continue reading →
Items of recent pandemic news: Minnesota’s oddly bright prospects; Israel offers a fourth shot; the end of the pandemic as a social phenomenon; and what happens when Omicron hits a population with pre-existing immunity. Plus a frippery. Quotes of the … Continue reading →
Items of recent pandemic news: Those who pay zero attention to the pandemic; the evolutionary weirdness of Omicron; the class-based roots of vaccine avoidance; boosters authorized for people aged 16-17; and Paxlovid’s continuing promise. Plus a frippery. Paxlovid holds up … Continue reading →
Items of recent pandemic news: Quantifying the immunity advantage over natural infection that you get from boosting; nucleotide sequences released for the vaccines; an update on Omicron; and what we should do about it right now. Plus a frippery. Quotes … Continue reading →
Items of recent pandemic news: How the sex of the fetus affects a mother’s immune response to the coronavirus; the prospect for vaccination in ages 5-11; boosters authorized in mix-and-match format; and more. Plus a frippery. Boosters for most everyone … Continue reading →
Items of recent pandemic news: Auto-antibodies in long Covid; Moderna’s durability benefit over Pfizer; results from Johnson & Johnson’s two-dose trial; Pfizer’s effectiveness in kids 5-11; and who gets a Pfizer booster. Plus a frippery. FDA, CDC committee approve boosters … Continue reading →
Items of recent pandemic news: How to fix indoor air; Covid-sniffing dogs at Miami airport; an account of a “mild” breakthrough case of Covid-19; and today’s pivotal FDA meeting on boosters. Plus two fripperies. The booster debate comes to a … Continue reading →
Items of recent pandemic news: Vaccination halves chances of long Covid; the role of auto-antibodies in severe disease; rising out-of-pocket costs of Covid; the unlikelihood that September 20 will see booster shots; and more. Plus a frippery. 1. Boosters will … Continue reading →
Two senior FDA officials have resigned — “giants who helped bring us many safe and effective vaccines over decades of public service,” according to a former FDA scientist — reportedly in protest of political meddling in the work of the … Continue reading →
Items of recent pandemic news you may have missed: Delta Air Lines’ strong encouragement for vaccination; contaminated vaccine in Japan; good news on a J&J booster; and the dent approval is not making in vaccine hesitancy. Plus two fripperies. Approval … Continue reading →
Items of recent pandemic news: Is the FDA moving too fast or too slow? Flying blind on Delta breakthrough data; an early hint that boosters do what was hoped; and full FDA approval for Pfizer / BioNTech. Plus a frippery. … Continue reading →
Items of recent pandemic news you may have missed: The youngest children are strong spreaders of SARS-CoV-2; all the Covid-19 deaths that did not happen; the case against US booster shots; and more. Plus a frippery. 1. Against boosters The … Continue reading →
Items of recent pandemic news: Saliva tests may not be sensitive enough for the asymptomatic; early antiviral promise for a cholesterol-lowering drug; booster shots coming to the immunocompromised and then to all US citizens; and more. Plus a frippery. 1. … Continue reading →
Items of recent pandemic news: China will donate 2 billion doses; the unvaxxed consider shots more dangerous than Covid-19; FDA is fast-tracking full approval for Pfizer; countries and the WHO weigh booster shots; and more. Plus a frippery. 1. Pfizer … Continue reading →
Items of recent pandemic news you may have missed: Emergent gets a manufacturing green light; an antibody cocktail is authorized for prophylaxis; the nations planning to issue booster doses; and the whiplash engendered by the delta variant. Plus a frippery. … Continue reading →
